398
Participants
Start Date
October 31, 2012
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Blazer Open-Irrigated Ablation Catheter (Boston Scientific)
FDA Approved Open-Irrigated Ablation Catheter
Hospital Clinico Y Provincial, Barcelona
New York University, New York
Mt. Sinai Medical Center, New York
Charité University Berlin, Berlin
Strong Memorial Hospital of the University of Rochester, Rochester
Hospital of the University of Pennsylvania, Philadelphia
Union Memorial Hospital, Baltimore
University of Virginia, Charlottesville
Sentara Norfolk General Hospital, Norfolk
University of North Carolina Medical Center, Chapel Hill
Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
Georgia Health Sciences University, Augusta
Clínica Universitaria de Navarra, Pamplona
St. Vincent's Medical Center, Jacksonville
Baptist Hospital, Pensacola
CHU of Bordeaux, Pessac
Tampa General Hospital, Tampa
University of Alabama at Birmingham, Birmingham
Hunstville Hospital, Huntsville
Ohio State University Medical Center, Columbus
William Beaumont Hospital, Royal Oak
Trinity Mother of Frances Health System, Tyler
Staedtisches Klinikum Karlsruhe, Karlsruhe
University of Texas Health Science Center, Houston
Texas Cardiac Arrhythmia Research Foundation, Austin
Sequoia Hospital, Redwood City
University of California, San Francisco, San Francisco
Yale University, New Haven
Caritas St. Elizabeth's Medical Center, Boston
University of Michigan, Ann Arbor
Jersey Shore University Medical Center, Neptune City
Heart Care Partners, Brisbane
Royal Adelaide Hospital, Adelaide
Na Homolce Hospital, Prague
Centro Hospital de Santa Cruz, Carnaxide
Karolinska University Hospital, Stockholm
Golden Jubilee National Hospital, Glasgow
Lead Sponsor
Boston Scientific Corporation
INDUSTRY